CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF

Use of clozapine is attended with the serious though rare risk of agranulocytosis. Clozapineinduced agranulocytosis is reversible with the use of cytokines like granulocyte-colony stimulating factor (G-CSF). Reports of the haematological complication of clozapine have not been forthcoming from India...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, T.N., Thomas, Kuruvilla
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 1998
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964822/
https://www.ncbi.nlm.nih.gov/pubmed/21494447
_version_ 1782189443713597440
author Srinivasan, T.N.
Thomas, Kuruvilla
author_facet Srinivasan, T.N.
Thomas, Kuruvilla
author_sort Srinivasan, T.N.
collection PubMed
description Use of clozapine is attended with the serious though rare risk of agranulocytosis. Clozapineinduced agranulocytosis is reversible with the use of cytokines like granulocyte-colony stimulating factor (G-CSF). Reports of the haematological complication of clozapine have not been forthcoming from India though it has been in use for nearly three years. This report is on an young patient who developed total absence of granulocytes during the 4th month of treatment who was successfully treated with G-CSF.
format Text
id pubmed-2964822
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29648222011-04-14 CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF Srinivasan, T.N. Thomas, Kuruvilla Indian J Psychiatry Case Report Use of clozapine is attended with the serious though rare risk of agranulocytosis. Clozapineinduced agranulocytosis is reversible with the use of cytokines like granulocyte-colony stimulating factor (G-CSF). Reports of the haematological complication of clozapine have not been forthcoming from India though it has been in use for nearly three years. This report is on an young patient who developed total absence of granulocytes during the 4th month of treatment who was successfully treated with G-CSF. Medknow Publications 1998 /pmc/articles/PMC2964822/ /pubmed/21494447 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Srinivasan, T.N.
Thomas, Kuruvilla
CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
title CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
title_full CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
title_fullStr CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
title_full_unstemmed CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
title_short CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
title_sort clozapine-induced agranulocytosis and use of g-csf
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964822/
https://www.ncbi.nlm.nih.gov/pubmed/21494447
work_keys_str_mv AT srinivasantn clozapineinducedagranulocytosisanduseofgcsf
AT thomaskuruvilla clozapineinducedagranulocytosisanduseofgcsf

Ejemplares similares